Abstract:The performance of small-diameter vascular grafts adapted to vascular replacement is commonly hin-dered by stenosis. To address this issue, a graft featuring rapid remodeling with degradation is war-ranted. In this work, a 1.8-mm-diameter graft was constructed by fabricating a decellularized human amniotic membrane (HAM) with polycaprolactone (PCL)/silk fibroin (SF) around it through electrospin-ning, namely, an HPS graft, and applied in a rat aortic grafting model for comparison to a decellularized porcine small intestinal submucosa (SIS)-integrated PCL/SF (SPS) graft and an autologous aorta. In vitro studies demonstrated that HAM provided a bioactive milieu for rapid endothelial cell proliferation and re-sisting fibroblast-induced collagen secretion. PCL/SF provides a biocompatible microenvironment for cel-lular infiltration with mechanical properties resembling those of the rat aorta. In vivo studies showed that the HPS graft induced functional endothelialization more rapidly, along with less intensive ECM deposi-tion than the SPS graft upon the histologically weaker inflammatory response and foreign body reaction 4 weeks after implantation, and maintained patency by progressively stabilizing the remodeling structure approximating the native counterparts over 24 weeks. The bioengineered graft expands the applicability of allogeneic matrices with degradable electrospun polymers for long-term in situ vascular applications.Statement of significanceAn orchestrated remodeling of the vascular graft, featuring rapid endothelialization and resisting extracel-lular matrix (ECM) deposition on the luminal surface, with a mechanically stable structure, is requisite for long-term vascular patency. Nevertheless, off-the-shelf grafts might not fulfil the criteria under abdom-inal aortic pressure. Herein, we fabricated a 1.8-mm-diameter vascular graft through the integration of a decellularized human amniotic membrane (HAM) with electrospun polycaprolactone (PCL)/silk fibroin (SF). In a rat aortic grafting model, the graft is capable of rapid endothelialization and resisting collagen deposition and provides a native-like mechanical structure for stabilizing the remodeling process towards that of the native aorta. This bioengineered graft has potential for small-diameter vascular regeneration, and provides advanced strategies to facilitate full-remodeling tissue applications.(c) 2022 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Construction of Enzyme-Laden Vascular Scaffolds Based on Hyaluronic Acid Oligosaccharides-Modified Collagen Nanofibers for Antithrombosis and In-Situ Endothelialization of Tissue-Engineered Blood Vessels.

Bioinspired, Artificial, Small-Diameter Vascular Grafts with Selective and Rapid Endothelialization Based on an Amniotic Membrane-Derived Hydrogel.

Engineered Vascular Graft Using Nanoscale Decellularized Arteries Modified with Controlled-Release Heparin and Vascular Endothelial Growth Factor

Nanofibrous Vascular Scaffold Prepared from Miscible Polymer Blend with Heparin/stromal Cell-Derived Factor-1 Alpha for Enhancing Anticoagulation and Endothelialization

Hyaluronic Acid Oligosaccharide-Modified Collagen Nanofibers As Vascular Tissue-Engineered Scaffold for Promoting Endothelial Cell Proliferation.

Co-immobilization of ACH11 Antithrombotic Peptide and CAG Cell-Adhesive Peptide Onto Vascular Grafts for Improved Hemocompatibility and Endothelialization.

Fabrication and Assessment of Chondroitin Sulfate-Modified Collagen Nanofibers for Small-Diameter Vascular Tissue Engineering Applications.

Biologically responsive, long-term release nanocoating on an electrospun scaffold for vascular endothelialization and anticoagulation

Customized Vascular Repair Microenvironment: Poly(lactic acid)-Gelatin Nanofibrous Scaffold Decorated with bFGF and Ag@Fe3O4 Core-Shell Nanowires

Construction of Tissue-Engineered Vascular Grafts with Enhanced Patency by Integrating Heparin, Cell-Adhesive Peptide, and Carbon Monoxide Nanogenerators into Acellular Blood Vessels

Improved Hemocompatibility and Endothelialization of Vascular Grafts by Covalent Immobilization of Sulfated Silk Fibroin on Poly(Lactic-Co-Glycolic Acid) Scaffolds

Biomimetic Tubular Scaffold with Heparin Conjugation for Rapid Degradation in in Situ Regeneration of a Small Diameter Neoartery.

Heparinization and Hybridization of Electrospun Tubular Graft for Improved Endothelialization and Anticoagulation.

Fabrication and Comprehensive Characterization of Biomimetic Extracellular Matrix Electrospun Scaffold for Vascular Tissue Engineering Applications

Surface modification with hydrophilic and heparin-loaded coating for endothelialization and anticoagulation promotion of vascular scaffold

Preparation and in Vivo Evaluation of Surface Heparinized Small Diameter Tissue Engineered Vascular Scaffolds of Poly(ε-Caprolactone) Embedded with Collagen Suture.

Multifunctional nanoparticle-VEGF modification for tissue-engineered vascular graft to promote sustained anti-thrombosis and rapid endothelialization

Untangling the co-effects of oriented nanotopography and sustained anticoagulation in a biomimetic intima on neovessel remodeling.

Development of a Decellularized Human Amniotic Membrane-Based Electrospun Vascular Graft Capable of Rapid Remodeling for Small-Diameter Vascular Applications.

The Synergistic Effect of Aligned Nanofibers and Hyaluronic Acid Modification on Endothelial Cell Behavior for Vascular Tissue Engineering.

Engineering the Mechanical and Biological Properties of Nanofibrous Vascular Grafts for in Situ Vascular Tissue Engineering.